NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.News, Brian Armstrong, CoinbaseRead More

You might also be interested in reading Solana price reclaims $200 on whale-led rebound, will recovery hold?.